Sontag Advisory »

Lineage Cell Therapeutics In shares owned by Sontag Advisory

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $149 88 1.69

More positions owned by Sontag Advisory

iShares Core S&P 500 ETF Etf (IVV)
Vanguard MSCI EAFE ETF Etf (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab International Equity ETF Etf (SCHF)
Vanguard FTSE Emerging Markets ETF Etf (VWO)
Vanguard Index Fds Growth Etf (VUG)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Extended Market ETF Etf (VXF)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Sontag Advisory

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In